31.03.2020 Views

BDI-International Magazine - Inaugural Issue

Best Doctors Insurance magazine

Best Doctors Insurance magazine

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Members of the award-winning UHealth Tower Stroke Team, from left, David Lang, D.O., Christina Pacheco, Eldorana Pust, Aliercy Nunez<br />

Sanchez, Tara Michelle Cheung, RN, Sebastian Koch, M.D., Michael Greenberg, M.D., Shane Soorus, RN, Julianne Lee Burgos, Betty Hanley,<br />

Cathy Rosenberg, MSN, ARNP-BC, Amanda Demane, SLP, and Miguel Garcia.<br />

ensuring that stroke patients receive the<br />

most appropriate treatment according to<br />

nationally recognized, research-based<br />

guidelines based on the latest scientific<br />

evidence.<br />

UHealth Tower earned the award by<br />

meeting specific quality achievement<br />

measures for the diagnosis and treatment<br />

of stroke patients at a set level for a<br />

designated period. These measures<br />

include evaluation of the proper use of<br />

medications and other stroke treatments<br />

aligned with the most up-to-date,<br />

evidence-based guidelines with the goal<br />

of speeding recovery and reducing death<br />

and disability for stroke patients.<br />

“UHealth Tower is dedicated to improving<br />

the quality of care for our stroke patients<br />

by implementing the American Heart<br />

Association’s Get With The Guidelines-<br />

Stroke initiative,” said Sebastian Koch,<br />

M.D., professor of clinical neurology and<br />

chief of the Stroke Program at UHealth<br />

Tower. “The tools and resources provided<br />

help us track and measure our success in<br />

meeting evidenced-based clinical<br />

guidelines developed to improve patient<br />

outcomes.”<br />

UHealth Tower additionally received the<br />

AHA/ASA Target: Stroke Elite Plus<br />

Award. To qualify for this recognition,<br />

hospitals must meet quality measures<br />

developed to reduce the time between the<br />

patient’s arrival at the hospital and<br />

treatment with the clot-buster tissue<br />

plasminogen activator, or tPA, the only<br />

drug approved by the U.S. Food and Drug<br />

Administration to treat ischemic stroke.<br />

Specifically, the hospital has achieved an<br />

average time to thrombolytic therapy<br />

within 60 minutes in 75 percent or more<br />

of acute ischemic stroke patients treated<br />

with IV tPA and door-to-needle time<br />

within 45 minutes in 50 percent of acute<br />

ischemic stroke patients treated with IV<br />

tPA.<br />

“These awards represent the highest<br />

category of stroke center awards given by<br />

the AHA,” said David Sinclair, M.D.,<br />

M.B.A., UHealth chief patient safety and<br />

quality officer. “They are truly a great<br />

achievement and the result of tremendous<br />

work and dedication by a terrific<br />

multidisciplinary team.”<br />

<strong>BDI</strong> <strong>International</strong> <strong>Magazine</strong> | Page 20

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!